Episode
This CEO Is Advancing Neuroscience By Treating Pain & Epilepsy – Meet Dave Rosa, CEO, NeuroOne $NMTC
- Podcast
- Smart Money Circle
- Published
- Jun 12, 2026
- Duration seconds
- 1154
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/smart-money-circle-95624/episodes/this-ceo-is-advancing-neuroscience-by-treating-pain-epilepsy-meet-dave-rosa-ceo-neuroone-nmtc/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/smart-money-circle-95624/this-ceo-is-advancing-neuroscience-by-treating-pain-epilepsy-meet-dave-rosa-ceo-neuroone-nmtc.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
This CEO Is Advancing Neuroscience, Reducing Pain, & Treating Epilepsy – Meet Dave Rosa, CEO, NeuroOne Medical Technologies $NMTC Guest: Dave Rosa, CEO, NeuroOne Medical Technologies $NMTC Dave's Bio Dave Rosa is an entrepreneur with three decades of experience in the medical device industry spanning a variety of technologies and products. In addition to CEO roles with early-stage medical device companies, Mr. Rosa’s background also includes senior roles with C.R. Bard Inc., Boston Scientific Inc., and St. Jude Medical, where his responsibilities included marketing, product development and business development. He has been named as an inventor on multiple medical device patents, serves on seven corporate boards, and has raised $200M in the capital markets. Mr. Rosa holds an MBA from Duquesne University and a BS in Commerce and Engineering from Drexel University. Mr. Rosa currently serves as the President and CEO of NeuroOne (Nasdaq: NMTC), a medical technology company that develops high-definition, minimally invasive diagnostic and therapeutic devices based on its unique thin film electrode technology. NeuroOne, Nasdaq: NMTC Website https://nmtc1.com Company Bio NeuroOne Medical Technologies Corporation is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. NeuroOne markets a minimally invasive and high-definition/high-precision electrode technology platform with four FDA-cleared product families: Evo(R) Cortical Electrodes, Evo(R) sEEG Electrodes, OneRF(R) Ablation System (for brain), and OneRF(R) Trigeminal Nerve Ablation System. These solutions offer the potential to reduce the number of hospitalizations and surgical procedures, lower costs, and improve patient outcomes by offer…